In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Treatment of Pediatric Hydrocephalus: Update of the 2014 Guidelines

    • Mar 02, 2021
    • Isha Mondal, Austin, TX and Winson S. Ho, MD, Austin, TX

    • Pediatric

    • This updated guideline is the result of a planned five-year review of medical literature conducted by the Congress of Neurological Surgeons. This update discusses new and previous recommendations from the 2014 guidelines on the treatment of pediatric hydrocephalus (HC).
    • There are 1 new Level III and 1 new Level I recommendations while the rest of the guidelines remain unchanged. These include:

    Level III – Management of post hemorrhagic HC in premature infants:

    1. NEW: Neuro-endoscopic lavage is a feasible and safe option for removal of intraventricular clots and may decrease rate of shunt placement.

    Level I - Antibiotic-impregnated shunt systems vs conventional shunts to prevent shunt infection in children:

    1. NEW: Antibiotic-impregnated shunt tubing reduces risks of infection compared to the conventional silicone hardware and should be used for children who require shunt placement

     Confirmation of previous recommendations:

    • Technical assistance devices for ventricular placement: ultrasound is an option
    • Ventriculoperitoneal shunt (VPS) placement vs endoscopic third ventriculostomy (ETV) for pediatric HC: VPS and ETV are both viable options
    • Different shunt components for pediatric VPS: Valve types do not influence risk of shunt failure
    • Preoperative antibiotics for VPS: Use of preoperative antibiotic is recommended
    • Treatment of VPS infection: Supplementation of antibiotic treatment with partial or complete shunt hardware removal is an option
    • Ventricular catheter entry point on shunt survival: frontal and occipital entry points are both options
    • Change in ventricle size as a measurement of effective treatment of HC: insufficient evidence to recommend specific change in ventricle size as a measurement of timing and success of HC treatments including VPS and ETV

    Source

    Academic OUP

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy